EXPERIENCE WITH TWO PATIENTS WITH ACTIVATED PI3K DELTA SYNDROME: CASE REPORTS

被引:0
|
作者
Stoner, A.
Kennedy, J.
Berlinski, A.
Jones, S.
Scurlock, A.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P271
引用
下载
收藏
页码:S69 / S69
页数:1
相关论文
共 50 条
  • [41] International Retrospective Study of Allogeneic Hematopoietic Cell Transplantation (HCT) for Activated Phosphoinositide 3-Kinase Delta (PI3K) Syndrome
    Dimitrova, Dimana
    Nademi, Zohreh
    Maccari, Maria Elena
    Ehl, Stephan
    Lankester, Arjan C.
    Gennery, Andrew
    Uzel, Gulbu
    Laberko, Alexandra
    Mukhina, Anna
    Ip, Winnie
    Rao, Kanchan
    Worth, Austen J. J.
    Speckmann, Carsten
    Wehr, Claudia
    Abolhassani, Hassan
    Aghamohammadi, Asghar
    Bleesing, Jack J.
    Dara, Jasmeen
    Dvorak, Christopher C.
    Ghosh, Sujal
    Kang, Hyoung Fin
    Markelj, Gasper
    Modi, Arunkumar
    Bayer, Diana
    Notarangelo, Luigi D.
    Schulz, Ansgar
    Garcia-Prat, Marina
    Soler-Palacin, Pere
    Kurakukcu, Musa
    Yilmaz, Ebru
    Slatter, Mary
    Kanakry, Jennifer A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S14 - S15
  • [42] The Role of PI3kγ and PI3kΔ in Alloimmunity
    Uehara, M.
    Jamil, A.
    Solhjou, Z.
    McGrath, M.
    Banouni, N.
    Evans, C.
    Dinitto, J.
    Winkler, D.
    Abdi, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 325 - 325
  • [43] The role of PI3kγ and PI3kδ in alloimmunity
    Uehara, Mayuko
    Jamil, Azzi
    Ohori, Shunsuke
    Solhjou, Zhabiz
    McGrath, Martina
    Banouni, Naima M.
    Evans, Catherine A.
    Dinitto, Jonathan P.
    Winkler, David G.
    Abdi, Reza
    TRANSPLANTATION, 2016, 100 (07) : S361 - S361
  • [44] PI3K targeted inhibition in NSCLC: An in vitro evaluation and correlation of mutation status to activated PI3K pathway signaling in NSCLC patients
    Heavey, Susan
    Toomey, Sinead
    Carr, Aoife
    Cuffe, Sinead
    Finn, Stephen
    Hennessy, Bryan
    Crown, John
    Barr, Martin
    O'Byrne, Kenneth
    Gately, Kathy
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
  • [45] Bringing PI3K Delta Inhibitors to Cancer Treatment
    不详
    CANCER DISCOVERY, 2011, 1 (01) : OF4 - OF4
  • [46] Highly delta selective quinazolinone PI3K inhibitors
    Treiberg, Jennifer
    Chandrasekhar, Jayaraman
    Ip, Carmen
    Koditek, David
    Lepist, Eve-Irene
    McGrath, Mary
    Mwangi, Judy
    Perreault, Stephane
    Somoza, John
    Steiner, Bart
    Therrien, Joseph
    Villasenor, Armando
    Wise, Sarah
    Wong, Belinda
    Phillips, Gary
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [47] Disorders Related to PI3Kδ Hyperactivation: Characterizing the Clinical and Immunological Features of Activated PI3-Kinase Delta Syndromes
    Redenbaugh, Vyanka
    Coulter, Tanya
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [48] Interim Analysis of Safety and Hematological Parameters of an Ongoing Long-Term Open-Label Extension Study of Investigational PI3Kδ Inhibitor Leniolisib for Patients with Activated PI3K Delta Syndrome (APDS) through December 2021
    Rao, V. Koneti
    Webster, Sharon
    Sediva, Anna
    Plebani, Alessandro
    Schuetz, Catharina
    Shcherbina, Anna
    Dalm, Virgil A. S. H.
    Trizzino, Antonino
    Zharankova, Yulia
    Kulm, Elaine
    Orpia, Alanvin
    Kluczynski, Lavenda Chirombo
    Koerholz, Julia
    Lougaris, Vassilios
    Rodina, Yulia
    Kucher, Klaus
    Radford, Kath
    Bradt, Jason
    Uzel, Gulbu
    BLOOD, 2022, 140 : 1643 - 1645
  • [49] INTUSSCEPTION: A NOVEL PRESENTATION OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE-Δ (PI3KΔ) SYNDROME (APDS)
    Gold, M.
    Chan, D.
    Marchand, B.
    Dzeladini, L.
    King, J.
    Cheung, A.
    Quinn, P.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 28 - 29
  • [50] Endoscopic airway manifestations in a pediatric patient with activated PI3K-delta syndrome
    Williams, Sophia N.
    PEDIATRIC PULMONOLOGY, 2020, 55 (11) : 2836 - 2837